Ex vivo-expanded highly pure ABCB5+ mesenchymal stromal cells as Good Manufacturing Practice-compliant autologous advanced therapy medicinal product for clinical use: process validation and first in-human data-Reference-Cited by-同舟云学术

Ex vivo-expanded highly pure ABCB5+ mesenchymal stromal cells as Good Manufacturing Practice-compliant autologous advanced therapy medicinal product for clinical use: process validation and first in-human data

Published:2021-02 Issue:2 Volume:23 Page:165-175
ISSN:1465-3249
Container-title:Cytotherapy
language:en
Short-container-title:Cytotherapy

Author:

Kerstan Andreas,Niebergall-Roth Elke,Esterlechner Jasmina,Schröder Hannes M.,Gasser Martin,Waaga-Gasser Ana M.,Goebeler Matthias,Rak Katrin,Schrüfer Philipp,Endres Sabrina,Hagenbusch Petra,Kraft Korinna,Dieter Kathrin,Ballikaya Seda,Stemler Nicole,Sadeghi Samar,Tappenbeck Nils,Murphy George F.,Orgill Dennis P.,Frank Natasha Y.,Ganss Christoph,Scharffetter-Kochanek Karin,Frank Markus H.,Kluth Mark A.

Publisher

Elsevier BV

Subject

Cancer Research,Transplantation,Cell Biology,Genetics(clinical),Oncology,Immunology,Immunology and Allergy

Reference54 articles.

1. Impact and challenges of mesenchymal stem cells in medicine: an overview of the current knowledge;Menaa;Stem Cells Int,2018

2. Enhancement of functionality and therapeutic efficacy of cell-based therapy using mesenchymal stem cells for cardiovascular disease;Yun;Int J Mol Sci,2019

3. The role of mesenchymal stem cells in hematopoietic stem cell transplantation: prevention and treatment of graft-versus-host disease;Zhao;Stem Cell Res Ther,2019

4. Mesenchymal stem cell-based immunomodulation: properties and clinical application;Wang;Stem Cells Int,2018

5. Mesenchymal stromal cells as a potential therapeutic for neurological disorders;Mukai;Regen Ther,2018

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-Inflammatory and Anti-(Lymph)angiogenic Properties of an ABCB5+ Limbal Mesenchymal Stem Cell Population;International Journal of Molecular Sciences;2024-09-07

2. The uniqueness of ABCB5 as a full transporter ABCB5FL and a half-transporter-like ABCB5β;Cancer Drug Resistance;2024-08-07

3. Epidermolysis Bullosa: A Review of Wound Care and Emerging Treatments;Current Dermatology Reports;2024-07-30

4. Potency assay to predict the anti-inflammatory capacity of a cell therapy product for macrophage-driven diseases: overcoming the challenges of assay development and validation;Cytotherapy;2024-05

5. Clinical-grade human skin-derived ABCB5+ mesenchymal stromal cells exert anti-apoptotic and anti-inflammatory effects in vitro and modulate mRNA expression in a cisplatin-induced kidney injury murine model;Frontiers in Immunology;2024-01-11